{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:03:34Z","timestamp":1778277814396,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T00:00:00Z","timestamp":1092700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Aim:\u2002<\/jats:bold> To study the teratogenicity of oral griseofulvin during pregnancy.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The data of the population\u2010based Hungarian Case\u2013Control Surveillance of Congenital Abnormalities between 1980 and 1996 and the Hungarian Congenital Abnormality Registry between 1970 and 2002 were evaluated.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> In total, 38\u2003151 pregnant women who delivered newborn infants without any defects (control group) and 22\u2003843 pregnant women who had fetuses or newborns with congenital abnormalities were included in the study. Seven (0.03%) case and 24 (0.06%) control pregnant women were treated with the griseofulvin (crude odds ratio with 95% confidence interval: 0.49, 0.21\u20131.13). A teratogenic potential of griseofulvin was not indicated by a comparison of the expected and observed number of different congenital abnormalities. A higher mean birth weight was found in control newborn infants born to mothers with griseofulvin treatment compared with the data of control newborn infants without this treatment. In addition, 55 conjoined twins were evaluated in the data set of the Hungarian Congenital Abnormality Registry, and no conjoined twins had mother with griseofulvin treatment during pregnancy.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Our data do not indicate a detectable teratogenic risk of oral griseofulvin treatment during pregnancy; however, the numbers of cases and controls were limited. Therefore, international collaboration is needed for the final conclusion.<\/jats:p>","DOI":"10.1111\/j.0001-6349.2004.00598.x","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T16:09:11Z","timestamp":1092758951000},"page":"827-831","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A population\u2010based case\u2013control study of oral griseofulvin treatment during pregnancy"],"prefix":"10.1111","volume":"83","author":[{"given":"Andrew E.","family":"Czeizel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia","family":"M\u00e9tneki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Kazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Puho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,17]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81262-5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)34797-4"},{"key":"e_1_2_5_4_2","volume-title":"Allgemeine und spezielle Pharmakologie und Toxikologie","author":"Forth W","year":"1996"},{"key":"e_1_2_5_5_2","first-page":"44","article-title":"Teratogenic effect of griseofulvin\u2010forte on rat fetus","volume":"14","author":"Slonitskaya NN.","year":"1969","journal-title":"Russian) Antibiotik"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.175.4029.1483"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420110110"},{"key":"e_1_2_5_8_2","first-page":"161","volume-title":"Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks in New Drugs. Proceedings of the 3rd Symposium on Toxicological Testing for Safety of New Drugs","author":"Jindra J","year":"1979"},{"key":"e_1_2_5_9_2","first-page":"167","article-title":"Teratogenicity of antibiotics","volume":"38","author":"Tanimura T.","year":"1975","journal-title":"Shonika Rinsho (J Pediat Pract) (Japanese)"},{"key":"e_1_2_5_10_2","volume-title":"Clinical Aspects of the Teratogenicity of Drugs","author":"Nishimura H","year":"1976"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92015-0"},{"key":"e_1_2_5_12_2","first-page":"17","article-title":"Griseofulvin: a new formulation and some old concerns","volume":"18","author":"Anonymous","year":"1976","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1032"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199705)55:5<299::AID-TERA1>3.0.CO;2-V"},{"key":"e_1_2_5_15_2","first-page":"285","article-title":"Conjoined twins in Hungary, 1970\u201386","volume":"38","author":"M\u00e9tneki J","year":"1989","journal-title":"Acta Genet Med Gemellol"},{"key":"e_1_2_5_16_2","first-page":"1297","article-title":"Analysis of medical indications for induced abortion (Hungarian with English abstract)","volume":"124","author":"Czeizel AE.","year":"1983","journal-title":"Orvosi Hetilap"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.766"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200107000-00017"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92318-X"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91533-9"},{"key":"e_1_2_5_21_2","unstructured":"RosaF.Personal Communication 1993. In:BriggsGGet al. 1998."},{"key":"e_1_2_5_22_2","first-page":"493","volume-title":"Drugs in Pregnancy and Lactation","author":"Briggs GG","year":"1998"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00598.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00598.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0001-6349.2004.00598.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:08:25Z","timestamp":1697404105000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.0001-6349.2004.00598.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,17]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.0001-6349.2004.00598.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0001-6349.2004.00598.x","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,17]]},"assertion":[{"value":"2004-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}